(Q46600626)

English

Effective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab.

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Effective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Markus Alexander Zeitlinger

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

M Schmidinger

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

C C Zielinski

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

A Chott

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

M Raderer

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 May 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Leukemia & Lymphoma

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

46

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

771-774

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

The Revised European-American Classification of Lymphoid Neoplasms (REAL): a new perspective for the classification of cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1080%2F10428190400028959

21 January 2018

Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190400028959

21 January 2018

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F10428190400028959

21 January 2018

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1080%2F10428190400028959

21 January 2018

Primary structure of CD52.

1 reference

https://api.crossref.org/works/10.1080%2F10428190400028959

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400028959

21 January 2018

Alemtuzumab in lymphoproliferate disorders

1 reference

https://api.crossref.org/works/10.1080%2F10428190400028959

21 January 2018

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://api.crossref.org/works/10.1080%2F10428190400028959

21 January 2018

Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190400028959

21 January 2018

Identifiers

10.1080/10428190400028959

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

release_qrp3bfcg3rfctgadudo6sehjf4

1 reference

https://api.fatcat.wiki/v0/release/qrp3bfcg3rfctgadudo6sehjf4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019517%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46600626&oldid=1840323863"